Influence of asthma status on serotype-specific pneumococcal antibody levels

Postgraduate Medicine

Volumn 122, Issue 5, 2010, Pages 116-124

  Jung, Ji A ^a   Kita, Hirohito ^a   Dhillon, Ravneet ^a   Jacobson, Robert M ^a   Nahm, Moon H ^b   Park, Miguel ^a   Tsigrelis, Constantine ^a   Juhn, Young J ^a  

^a MAYO CLINIC   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Asthma; Epidemiology; Humoral immunity; Pneumococcal pneumonia; Pneumococcal polysaccharide antigens; PPV23; Risk; Rochester Epidemiology Project; Serotype specific pneumococcal antibody

Indexed keywords

BACTERIUM ANTIBODY; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 5; PNEUMOCOCCUS ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; STAPHYLOCOCCUS ENTEROTOXIN B; UNCLASSIFIED DRUG; BACTERIAL POLYSACCHARIDE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DETECTION; ASTHMA; CAUCASIAN; CHILD; CLINICAL ARTICLE; COMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DERMATOPHAGOIDES; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; MALE; MEDICAL RECORD REVIEW; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; REVIEW; SEROTYPE; TH2 CELL; UNITED STATES; VACCINATION; ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEUTROPHIL; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ASTHMA; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-5; MALE; MIDDLE AGED; NEUTROPHILS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 78049499520     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.09.2208     Document Type: Review

References (43)

1. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1-24.
2. Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002;51(2):98-104.
3. Talbot TR, Hartert, TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082-2090.
4. Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122(4):719-723.
5. Centers for Disease Control and Prevention. ACIP provisional recommendations for the use of pneumococcal vaccines. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
6. Luo R, Mann B, Lewis WS, et al. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. Embo J. 2005;24(1):34-43.
7. Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev. 2005;206:83-99.
8. Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(1):31-44.
9. Juhn YJ, Kita H, Yawn BP, Boyce T, Jacobson RM. The potential mechanisms for increased risk of serious pneumococcal diseases in asthmatics. J Allergy Clin Immunol. In press.
10. Sjölander A, Baldwin TM, Curtis JM, Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J Immunology. 1998;160(8):3949-3957.
11. Chaplin D, Zindl C, Duffy L, Atkinson T, Lai J. Clearance of Mycoplasma pneumoniae is impaired in mice with established allergic airway inflammation. J Allergy Clin Immunol. 2007;119:S132.
12. Kincy-Cain T, Clements JD, Bost KL. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun. 1996;64(4):1437-1440.
13. Beisswenger C, Kandler K, Hess C, et al. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol. 2006; 177(3):1833-1837.
14. van Den Broek M, Bachmann MF, Köhler G, et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol. 2000;164(1):371-378.
15. Fischer JE, Johnson JE, Kuli-Zade RK, et al. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol. 1997;71(11):8672-8677.
16. Romanni L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 response with acquired resistance. Infect Immun. 1991;59(12):4647-4654.
17. Smart JM, Kemp AS. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy. 2002;32(5):796-802.
18. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet. 2007;370(9596):1422-1431.
19. Khan AQ, Shen Y, Wu ZQ, Wynn TA, Snapper CM. Endogenous pro-and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun. 2002; 70(2):749-761.
20. Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine. 2008;26(43):5541-5546.
21. Conaty S, Watson L, Dinnes J, Waugh N. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomized controlled trials. Vaccine. 2004;22(23-24):3214-3224.
22. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192(3):387-393.
23. Hanania NA, Sockrider M, Castro M, et al; American Lung Association Asthma Clinical Research Centers. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004;113(4):717-724.
24. Verstraeten T, Jumaan AO, Mullooly JP, et al; Vaccine Safety Datalink Research Group. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98-e103.
25. Jacob GL, Homburger HA. Simultaneous quantitative measurement of IgG antibodies to streptococcus pneumoniae serotypes by microsphere photometry. J Allergy Clin Immunol. 2004;113:S288.
26. Sorensen RU, Leiva LE, Javier FC 3rd, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol. 1998;102(2):215-221.
27. Rubins JB, Janoff EN. Pneumococcal disease in the elderly: what is preventing vaccine efficacy? Drugs Aging. 2001;18(5):305-311.
28. Silverstein MD, Reed CE, O'Connell EJ, et al. Long-term survival of a cohort of community residents with asthma. New Engl J Med. 1994;331(23):1537-1541.
29. Hunt LW Jr, Silverstein MD, Reed CE, et al. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA. 1993;269(15):1947-1952.
30. Juhn YJ, Weaver A, Katusic S, Yunginger, J. Mode of delivery at birth and development of asthma: a population-based cohort study. J Allergy Clin Immunol. 2005;116(3):510-516.
31. Heaton T, Mallon D, Venaille T, Holt P. Staphylococcal enterotoxin induced IL-5stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? Allergy. 2003;58(3):252-256.
32. Yu J, Carvalho Mda G, Beall B, Nahm MH. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol. 2008;57(pt 2):171-178.
33. Lee HJ, Kang JH, Henrichsen J, et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine. 1995;13(16):1533-1538.
34. Arkwright P, Patel L, Haeney MR, Ewing CI, David TJ. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin Exp Immunol. 2000;122(1):16-19.
35. Grove DI, Burston TO, Wellby ML, Ford RM, Forbes IJ. Humoral and cellular immunity in asthma. J Allergy Clin Immunol. 1975;55(3):152-163.
36. Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassel GH. Deficient immune respone to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 2009;30(2):158-165.
37. Yoo KH, Butterfield M, Jacobson RM, Poland GA, Juhn YJ. Assessment of humoral and cell-mediated immune response to MMR vaccine viruses among patients with asthma. Allergy Asthma Proc. In press.
38. Schneider LC, Weinberg A, Boguniewicz M, et al. Abnormal immune response to varicella vaccine in subjects with atopic dermatitis compared to non-atopic controls. J Allergy Clin Immunol. 2008;121(2suppl 1):S272-S273.
39. Griffioen AW, Toebes EA, Rijkers GT, Claas FH, Datema G, Zegers BJ. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol Lett. 1992;32(3):265-272.
40. Khan AQ, Lees A, Snapper CM. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J Immunol. 2004;172(1):532-539.
41. Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746.
42. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784-1792.
43. Tsigrelis C, Tleyjeh I, Lahr B, Virk A, Baddour L. Temporal trends in invasive pneumococcal disease-a population-based study in Olmsted County, Minnesota, 1999-2006. Abstract number 933 presented at: 45th Annual Meeting of the Infectious Diseases Society of America (ISDA); San Diego, CA; October 4-7, 2007.